M0379SExonuclease VII and 1 more item

Virginia Commonwealth University awarded a contract to New England Biolabs Inc. on June 3, 2026, for the procurement of molecular biology reagents and enzymes. The contract, designated A236_P0339398, is valued at $261 and is being performed for VCU Procurement in Virginia. The contract encompasses two distinct line items: Exonuclease VII, procured at a unit price of $185.25, and SphI HF restriction enzyme, procured at a unit price of $76.00.

New England Biolabs Inc. is responsible for delivering these molecular biology products to Virginia Commonwealth University's procurement department. The line items represent standard research-grade biological reagents commonly utilized in molecular biology laboratories for DNA manipulation and analysis applications. Both items are procured as single unit purchases, with no extended performance period indicated in the contract documentation.